Development
DexCom, Inc.
DXCM
$82.26
$1.642.03%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 256.30M | 120.70M | 115.90M | 48.60M | 91.80M |
| Total Depreciation and Amortization | 69.00M | 48.20M | 43.70M | 41.60M | 52.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.40M | -62.70M | -16.10M | 13.70M | 54.00M |
| Change in Net Operating Assets | -258.10M | 163.00M | 46.80M | 51.50M | -66.00M |
| Cash from Operations | 133.60M | 269.20M | 190.30M | 155.40M | 132.50M |
| Capital Expenditure | -52.50M | -50.40M | -59.00M | -74.70M | -63.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 467.40M | -129.10M | -496.90M | -112.00M | -130.60M |
| Cash from Investing | 414.90M | -179.50M | -555.90M | -186.70M | -194.10M |
| Total Debt Issued | 0.00 | 0.00 | 1.23B | -- | -- |
| Total Debt Repaid | -136.80M | -650.50M | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 14.30M | 0.00 | 12.30M | 0.00 |
| Repurchase of Common Stock | -500.00M | 0.00 | -188.70M | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.90M | -1.20M | -102.40M | -1.10M | -1.00M |
| Cash from Financing | -631.90M | -637.40M | 939.50M | 11.20M | -1.00M |
| Foreign Exchange rate Adjustments | 6.10M | -3.50M | -2.20M | 1.10M | 6.80M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.30M | -551.20M | 571.70M | -19.00M | -55.80M |